Kalvista Pharmaceuticals Inc (KALV) Insider Trading
- $45,015,517.47
- $69,649,984.03
- Sept. 9, 2024
- Thomas Andrew Crockett
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 14, 2017 | Major Shareholder | 10,000 | $8.05 | Sell | $80,500.00 | |
| Sept. 13, 2017 | Major Shareholder | 25,900 | $8.02 | Sell | $207,718.00 | |
| Dec. 30, 2015 | CEO | 10,000 | $3.70 | Sell | $37,000.00 | |
| April 14, 2015 | Director | 1,012,500 | $5.00 | Buy | $5,062,500.00 | |
| April 14, 2015 | Major Shareholder | 877,500 | $5.00 | Buy | $4,387,500.00 |
Insiders are both buying and selling Kalvista Pharmaceuticals Inc stock.
The insider traders at Kalvista Pharmaceuticals Inc are: Thomas Andrew Crockett, Christopher Yea, Venrock Healthcare Capital Par, Benjamin L Palleiko, Edward P Feener, Albert Cha, Svlsf Iv, Llc, Life Sciences Fund Iv (Gp) Sv, Holdings A/S Novo, Paul K Audhya, Andreas Maetzel, Acmp Iv Llc, David Renzi, Daniel B Soland, Rajeev M Shah, and Michael David Smith
The most active insider trader at Kalvista Pharmaceuticals Inc is Thomas Andrew Crockett with 22 trades.
Holdings A/S Novo has sold the most Kalvista Pharmaceuticals Inc stock with a total value of $54,105,299.11.
Albert Cha has bought the most Kalvista Pharmaceuticals Inc stock with a total value of $29,566,911.61.
The most recent insider trade for Kalvista Pharmaceuticals Inc was on Sept. 9, 2024.
The single biggest insider buy for Kalvista Pharmaceuticals Inc was from Albert Cha with a total value of $18,000,008.00 on Sept. 10, 2018.
The single biggest insider sell for Kalvista Pharmaceuticals Inc was from Holdings A/S Novo with a total value of $26,271,728.12 on Oct. 12, 2017.